Novo Nordisk, Pfizer and other big pharma companies have just taken [the hormone] GLP-1 itself, and spent 20 years stabilising the peptide, making it druggable, so its not broken down [in the body], explains John Unitt, vice president of immunology and inflammation drug discovery at Sygnature Discovery in Nottinghamshire, UK, and a GPCR drug discovery expert
Customer reviews are not provided for consumer reference
Formulation-specific factors Different GLP-1 formulations use different delivery technologies that produce unique reaction patterns
Raun et al
A private label GLP-1 capsule OEM/ODM product page focused on packaging, formula discussion, low-MOQ planning, documentation, and compliant B2B sourcing for supplement brands